Moneycontrol PRO
HomeNewsOrchidpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight: How should you trade Mastek, City Union Bank, Ceat, Jubilant Ingrevia, JTEKT India, and others on Monday?

    Given the improved sentiment after the counter-attack by bulls, the benchmark indices are expected to extend their upward rally amid possible consolidation. Below are some trading ideas for the near term.

  • Trade Spotlight: How should you trade Orchid Pharma, India Glycols, Inox Green Energy, NBCC, and others on Tuesday?

    Trade Spotlight: How should you trade Orchid Pharma, India Glycols, Inox Green Energy, NBCC, and others on Tuesday?

    A close above 24,500 could drive the Nifty 50 towards the 24,700-24,800 zone, but if it stays below this level, consolidation and range-bound trading may continue with 24,200 as support. Here are some trading ideas for the near term.

  • Buy Reliance Infra, OBC, Reliance Capital: Ashwani Gujral

    Buy Reliance Infra, OBC, Reliance Capital: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Reliance Infra, OBC and Reliance Capital.

  • Sell Orchid Pharma on rally, says Vijay Chopra

    Sell Orchid Pharma on rally, says Vijay Chopra

    Vijay Chopra of enochventures.com advises selling Orchid Pharma.

  • Exit Orchid Pharma, says Prakash Gaba

    Exit Orchid Pharma, says Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma.

  • Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar

    Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar

    Avinash Gorakshakar, Market Expert advises exiting Orchid Pharma and one can prefer Lupin and Sun Pharmaceutical Industries.

  • Exit Orchid Pharma closer to Rs 36: Prakash Gaba

    Exit Orchid Pharma closer to Rs 36: Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma closer to Rs 36.

  • Sell Orchid Pharma, says Prakash Gaba

    Sell Orchid Pharma, says Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may sell Orchid Pharma.

  • Bull's Eye: Buy Voltas, MCX India, Biocon; sell Hexaware

    Bull's Eye: Buy Voltas, MCX India, Biocon; sell Hexaware

    Manish Sharma of derivativetradingresearch is of the view that one may buy Voltas with a target of Rs 310.

  • Buy Rel Cap, Whirlpool, Wockhardt; sell United Breweries: Gujral

    Buy Rel Cap, Whirlpool, Wockhardt; sell United Breweries: Gujral

    Ashwani Gujral, fund manager at ashwanigujral.com is of the view that one can buy Reliance Capital, Whirlpool and Wockhardt and advises selling United Breweries.

  • Bull's Eye: Buy TVS Motor, BEL, Alembic, Auro Pharma

    Bull's Eye: Buy TVS Motor, BEL, Alembic, Auro Pharma

    Krish Subramanyam of Altamount Capital advises buying Alembic with a target of Rs 50.50.

  • Bull's Eye: Buy Hotel Leela, GMDC, Mindtree, sell OBC

    Bull's Eye: Buy Hotel Leela, GMDC, Mindtree, sell OBC

    Jay Thakkar of Sharekhan suggests buying Indraprastha Gas with a target of Rs 484.

  • Bull's Eye: Buy Ashoka Bulidcon, Dish TV, Arvind, Gati

    Bull's Eye: Buy Ashoka Bulidcon, Dish TV, Arvind, Gati

    Krish Subramanyam of Altamount Capital advises buying Orchid Chemicals with a target of Rs 67.

  • Buy HBL Power, Kesoram Ind, Orchid Chem: Krish Subramanyam

    Buy HBL Power, Kesoram Ind, Orchid Chem: Krish Subramanyam

    Krish Subramanyam of Altamount Capital recommends buying Orchid Chemicals for a target of Rs 65 and Aarti Industries.

  • Bull's Eye: Buy Dish TV, Orchid Chem, DHFL, GVK Power

    Bull's Eye: Buy Dish TV, Orchid Chem, DHFL, GVK Power

    Avinnash Gorakssakar of Precision Investment Services suggests buying Dish TV with a target of Rs 112.

  • Here are top 10 stocks to focus on December 23

    Here are top 10 stocks to focus on December 23

    Here are top 10 stocks to focus on December 23 - HDFC, SBI, Bank Nifty, Ipca Labs, HCL Tech, Intellect Design Arena, Max India, Rel Cap, NTPC and Gujarat Pipavav.

  • Orchid Chemicals may head above Rs 80: Pritesh Mehta

    Orchid Chemicals may head above Rs 80: Pritesh Mehta

    Pritesh Mehta of IIFL is of the view that Orchid Chemicals and Pharmaceuticals may head above Rs 80 and even test Rs 90-95.

  • Buy JM Financial, Orchid Chem; sell BOI: Krish Subramanyam

    Buy JM Financial, Orchid Chem; sell BOI: Krish Subramanyam

    Krish Subramanyam of Asit C Mehta Investment Intermediates recommends selling Bank of India for a target price of Rs 276 and Housing Development and Infrastructure for a target price of Rs 91.

  • Bull's Eye: Buy Venus Remedies, TNPL; short HDIL, Unitech

    Bull's Eye: Buy Venus Remedies, TNPL; short HDIL, Unitech

    Dharmesh Kant, IndiaNivesh Securities Private Limited advises buying Tamil Nadu Newsprint and Papers for a target price of Rs 172 and Pratibha Industries for a target price of Rs 73.

  • Exit Orchid Chemicals on rallies: Mayuresh Joshi

    Exit Orchid Chemicals on rallies: Mayuresh Joshi

    According to Mayuresh Joshi, VP- Institution at Angel Broking, one may exit Orchid Chemicals and Pharmaceuticals on rallies.

  • Exit Orchid Chemicals, says Kunal Saraogi

    Exit Orchid Chemicals, says Kunal Saraogi

    Kunal Saraogi, CEO at Equityrush is of the view that one may exit Orchid Chemicals and Pharmaceuticals on rallies.

  • Your Stocks: Recommendations by experts

    Your Stocks: Recommendations by experts

    Watch the interview of Mayuresh Joshi, VP- Institution at Angel Broking Ltd and Kunal Saraogi, CEO of Equityrush with Sumaira Abidi & Latha Venkatesh on CNBC-TV18, in which they both shared their reading and outlook on market and specific stocks.

  • Top 10 stocks: Keep an eye on HCL, Nestle, Kalindee Rail

    Top 10 stocks: Keep an eye on HCL, Nestle, Kalindee Rail

    Top 10 stocks that CNBC-TV18‘s research team says should be watched today are HCL Tech, Bharti Airtel, Tata Steel, Zee Ent, Nestle, Onmobile, JK Tyre, Orchid Chemicals, Mangalore Chemicals, and Kalindee Rail.

  • Buy Aurobindo Pharma, Orchid Chemicals on dips: Sukhani

    Buy Aurobindo Pharma, Orchid Chemicals on dips: Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may buy Aurobindo Pharma and Orchid Chemicals on dips.

  • Book profits in Orchid Chemicals: Shardul Kulkarni

    Book profits in Orchid Chemicals: Shardul Kulkarni

    Shardul Kulkarni of Angel Broking is of the view that one may book profits in Orchid Chemicals and Pharmaceuticals at around Rs 62-63.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347